It is that the drug is being used as the entire strategy instead of one part of a strategy
Novo Nordisk and Eli Lilly continue to dominate., Although Pfizer discontinued its in-house oral GLP-1 candidate danuglipron in April 2025 following a liver-injury signal, it has doubled back into obesity and GLP-1 with its multi-billion-dollar acquisition of Metsera
Goodman RE
Our compassionate healthcare providers work with you to build a weight loss plan tailored to your needs, lifestyle, and medical conditions, making safe, effective weight loss achievable
Kiran offers advanced medical facials, such as oxy facials, HydraFacial, and skin polishing that deeply cleanse and hydrate your skin while improving its brightness and tone
doi: 10.3390/biology13090692 78 DucyP